Frantz et al. investigated the association between TIMP-1 plasma levels and clinical endpoints (death due to any cause), and found that plasma TIMP-1 levels increased in HF patients as compared with healthy controls (1640 vs 735 ng/mL, respectively,) [60]. This evidence concerns the gene TIMP1 and hydrops fetalis.